Binding Site

Supplier Rating:

0.Reviews

Binding Site是一家专业蛋白公司，致力于全球实验室市场的创新免疫诊断的研究，开发，制造和分配。在抗体特异性技术中具有广泛的专业知识，绑定部位为临床医生和实验室工作人员提供了显着改善一系列癌症和免疫系统疾病的诊断和管理的工具。

绑定网站生产各种高品质的创新产品：

Freelite，一种新颖和高度显着的肿瘤标志物越来越多地用于多发性骨髓瘤的诊断，预后和监测，骨髓中细胞癌。多发性骨髓瘤是非霍奇金淋巴瘤后的第二个最常见的血癌。目前，每年有大约250万对的Freelite血清自由轻链测​​试，实验室分析的数量以大约的速度增加。50％p.a.

Hevylite, a new tumour marker complementary to Freelite, was launched in 2009 and is expected to provide clinicians with further information to manage patients with Multiple Myeloma and similar disorders.

原发性免疫缺陷疾病（PID）。

Binding Site is a market leader in the development of products for the investigation of PID (disorders in which part of the body’s immune system is missing or not functioning correctly). The current range of specialised products includes assays to measure specific antibody response to vaccination and assays to quantify immunoglobulins and IgG and IgA subclasses in human serum.

SPAPLUS is a fully supported, dedicated and reliable serum and plasma protein analyser which complements both the specialist Freelite, Hevylite and IgG subclass assays that Binding Site are well-known for, plus an expanding range of exciting new assays. The low maintenance SPAPLUS is compact, easy to use and provides a level of functionality usually seen only in larger systems.